Paper20176048
Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
Frau M and 3 others. Mol Aspects Med, 2010. Cited by 67 papers, by iCite.
Cite this record
ConductScience Library. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma. Papers, record 20176048. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20176048
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Biomarkers, Tumor | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Drug Delivery Systems | Major topic |
| Liver Neoplasms | Major topic |
| Animals | |
| Disease Progression | |
| Humans | |
| Prognosis | |
| Signal Transduction |
Source PubMed
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41426153 | Role of Dysregulated Immune Biomarkers in Hepatocellular Carcinoma Metastasis: A Systematic Meta-Analysis Review. | South Asian J Cancer | 2025 | https://conductscience.org/library/papers/41426153 | PubMed |
| 40264327 | Phytomolecules from Herbs: Possible Effective Way for the Treatment of Liver Cancer. | Curr Top Med Chem | 2025 | https://conductscience.org/library/papers/40264327 | PubMed |
| 38722372 | RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2024 | https://conductscience.org/library/papers/38722372 | PubMed |
| 38187282 | CSTB accelerates the progression of hepatocellular carcinoma via the ERK/AKT/mTOR signaling pathway. | Heliyon | 2024 | https://conductscience.org/library/papers/38187282 | PubMed |
| 37305689 | TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma. | Anal Cell Pathol (Amst) | 2023 | https://conductscience.org/library/papers/37305689 | PubMed |
| 36676960 | Genetic Predisposition to Hepatocellular Carcinoma. | Metabolites | 2022 | https://conductscience.org/library/papers/36676960 | PubMed |
| 34067095 | Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research. | Cells | 2021 | https://conductscience.org/library/papers/34067095 | PubMed |
| 32308683 | The DNMT1/miR-34a/FOXM1 Axis Contributes to Stemness of Liver Cancer Cells. | J Oncol | 2020 | https://conductscience.org/library/papers/32308683 | PubMed |
| 30533424 | Retinoblastoma Binding Protein 5 Correlates with the Progression in Hepatocellular Carcinoma. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/30533424 | PubMed |
| 30050996 | Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma. | Transl Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/30050996 | PubMed |
| 30008842 | Serum long noncoding RNA LRB1 as a potential biomarker for predicting the diagnosis and prognosis of human hepatocellular carcinoma. | Oncol Lett | 2018 | https://conductscience.org/library/papers/30008842 | PubMed |
| 29690860 | Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29690860 | PubMed |
| 29552208 | Apatinib promotes apoptosis of the SMMC-7721 hepatocellular carcinoma cell line via the PI3K/Akt pathway. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29552208 | PubMed |
| 29069753 | Loss of Barx1 promotes hepatocellular carcinoma metastasis through up-regulating MGAT5 and MMP9 expression and indicates poor prognosis. | Oncotarget | 2017 | https://conductscience.org/library/papers/29069753 | PubMed |
| 28978124 | SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma. | Oncotarget | 2017 | https://conductscience.org/library/papers/28978124 | PubMed |
| 28962366 | Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats. | Toxicol Rep | 2015 | https://conductscience.org/library/papers/28962366 | PubMed |
| 28714063 | MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto-oncogene and cyclin-dependent kinase 6 in mice. | Hepatology | 2017 | https://conductscience.org/library/papers/28714063 | PubMed |
| 28138610 | Sulfatase 1: a new Jekyll and Hyde in hepatocellular carcinoma? | Transl Gastroenterol Hepatol | 2016 | https://conductscience.org/library/papers/28138610 | PubMed |
| 27508177 | New insights on the role of epigenetic alterations in hepatocellular carcinoma. | J Hepatocell Carcinoma | 2014 | https://conductscience.org/library/papers/27508177 | PubMed |
| 27275496 | Focal loss of long non-coding RNA-PRAL, as determinant of cell function and phenotype of hepatocellular carcinoma. | Ann Transl Med | 2016 | https://conductscience.org/library/papers/27275496 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FOXM1 | 2305 | PubTator's text mining | https://conductscience.org/library/genes/2305 | NCBI Gene |
| ISYNA1 | 51477 | PubTator's text mining | https://conductscience.org/library/genes/51477 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20176048
GET https://conductscience.org/api/papers/v1/20176048/cited_by?page=2